- ►nih.gov [PDF] - Free from Publisher JB Jonas, JK Hayler, S Panda-Jonas - British Journal of Ophthalmology, 2000 - bjo.bmj.com METHODS The study included all 16 patients who underwent pars plana vitrectomy
for treatment of proliferative vitreoretinopathy, who received an intravitreal
injection of 10–20 mg crystalline triamcinolone acetonide at the end of ... Cited by 171 - Related articles - BL Direct - All 8 versions
JB Jonas, JK Hayler, A Söfker, S Panda- … - American journal of ophthalmology, 2001 - Elsevier RESULTS: At the end of the follow-up period, the retina was attached in 26 of
the 29 patients (89.7%). In three of the 29 patients (10.3%), a retinal
redetachment had occurred. None of the patients developed iris ... Cited by 214 - Related articles - BL Direct - All 9 versions
JB Jonas, JK Hayler, S Panda-Jonas - Graefe's Archive for Clinical and Experimental …, 2001 - Springer 0.2 ml. This procedure was repeated three times. Finally, the 0.2 ml con- tained
about 20 mg triamcinolone acetonide. Due to the dilution pro- cess, the 0.2 ml
contained about 1/625th of the original volume of the vehicle at a ... Cited by 47 - Related articles - BL Direct - All 2 versions
RJ Antcliff, DJ Spalton, MR Stanford, EM … - Ophthalmology, 2001 - Elsevier Six patients with chronic CME resistant to treatment with systemic steroids,
orbital floor steroids, and cyclosporine A. Three patients were followed for
more than 1 year, and the other three for between 3 and 9 months. Cited by 369 - Related articles - BL Direct - All 4 versions
T Hida, D Chandler, JE Arena, R Machemer - American journal of ophthalmology, 1986 - ncbi.nlm.nih.gov We tested the vehicles of six different commercially available depot
corticosteroids (Celestone Soluspan, Depo-Medrol, Decadron, Decadron LA,
Aristocort, and Kenalog) for possible toxicity when injected ... Cited by 186 - Related articles - All 3 versions
JB Jonas, JK Hayler, A Söfker, S Panda- … - Journal of Glaucoma, 2001 - journals.lww.com Cited Here...: The study included 14 eyes of 14 patients with secondary
neovascular glaucoma attributable to proliferative diabetic retinopathy (n = 9)
or ischemic central retinal vein occlusion (n = 5). All patients received ... Cited by 96 - Related articles - BL Direct - All 3 versions
RJ Wingate, PE Beaumont - Australian and New Zealand journal of ophthalmology, 1999 - ncbi.nlm.nih.gov PURPOSE: To ascertain whether intravitreal triamcinolone given for subretinal
neovascularization is associated with an ocular pressure rise. METHODS: A total
of 113 patients with angiographically proven subretinal neovascularization ... Cited by 185 - Related articles - BL Direct
- ►nih.gov [PDF] R Machemer, G Sugita, Y Tano - Transactions of the American Ophthalmological Society, 1979 - pubmedcentral.nih.gov INTRODUCTION FIBROUS PROLIFERATION INSIDE THE EYE AS IT IS FOUND AFTER INJURIES'
and in massive periretinal proliferation2 has regained considerable inter- est
since it has become possible to attack it surgically with the techniques ... Cited by 165 - Related articles - All 3 versions
RH Schindler, D Chandler, R Thresher, R … - American journal of ophthalmology, 1982 - ncbi.nlm.nih.gov Since high corticosteroid levels are important in achieving inhibition of
intraocular cellular proliferation, we studied the clearance of an
intravitreally injected slowly dissolving corticosteroid in the rabbit eye. ... Cited by 165 - Related articles
Y Tano, D Chandler, R Machemer - American journal of ophthalmology, 1980 - ncbi.nlm.nih.gov We studied the inhibitory effect of triamcinolone acetonide on experimental
intraocular proliferation. Autotransplantation of fibroblasts from rabbit rump
skin into the vitreous cavity resulted in intravitreal strand formation and ... Cited by 246 - Related articles
